European Archives - Page 1107 of 1425 - European Medical Journal

OLM Cells Could Hold the Key to Combatting Memory Loss in Alzheimer’s

Discovery of specific neurons in the brain involved in learning could lead to the development of new treatments that combat memory loss in Alzheimer’s…

Ozenoxacin as a Novel Treatment Option for Impetigo

Ozenoxacin has been shown to be a well-tolerated and effective treatment for impetigo patients ≥2 months old, according to results of a randomised…

Tralokinumab: A Safe and Effective Atopic Dermatitis Treatment

Tralokinumab is a fully human monoclonal antibody that has been shown to improve atopic dermatitis (AD) symptoms in patients with moderate-to-severe AD…

Diabetes During Pregnancy Increases Risk of Heart Defects in Babies

Babies are more likely to be born with heart defects if their mothers have Type 1 diabetes whilst pregnant, with the risk even more pronounced when these…

European Medical Journal Presents: EMJ Interventional Cardiology 6.1

The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy.

Dual Antiplatelet Therapy Challenges in Complex Clinical Scenarios

The symposium was a practical, case-based discussion in which four panellists each presented a real and challenging case regarding dual antiplatelet…

BVS STEMI STRATEGY-IT: 1-Year Results Following a Pre-Specified Absorb Implantation Strategy in ST-Segment Elevation Myocardial Infarction

ST-segment elevation myocardial infarction (STEMI) can represent a suitable scenario for the use of bioresorbable vascular scaffold technologies because…

Review of the EuroPCR Congress 2018

Nearly 11,000 participants from all over the world arrived at the heart of Paris, France for EuroPCR 2018. Torrential rain failed to put a dampener…

EMJ Interventional Cardiology 6.1 2018

The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy…

BVS Expand: Registry Turns 5 Years Old and Brings First Real Long-Term Results for the Everolimus-Eluting Bioresorbable Stent in Clinical Practice

The everolimus-eluting bioresorbable stent (BRS) Absorb BVS® (Abbott Vascular, Chicago, Illinois, USA), which is still considered the most widely…